Zobrazeno 1 - 10
of 48
pro vyhledávání: '"JunJiong Zheng"'
Autor:
Yi Huang, Zhijian Chen, Gang Shen, Shuogui Fang, Junjiong Zheng, Zepai Chi, Yuanfeng Zhang, Yitong Zou, Qinghua Gan, Chengxiao Liao, Yuhui Yao, Jianqiu Kong, Xinxiang Fan
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 20, Iss 1 (2024)
ABSTRACTThis study aims to conduct a bibliometric analysis, employing visualization tools to examine literature pertaining to tumor immune evasion related to anti-CTLA-4 and anti-PD-1/PD-L1 therapy from 1999 to 2022. A special emphasis is placed on t
Externí odkaz:
https://doaj.org/article/21c9f8870bdf41369ec5529eb545656b
Autor:
Junjiong Zheng, Jie Zhang, Jinhua Cai, Yuhui Yao, Sihong Lu, Zhuo Wu, Zhaoxi Cai, Aierken Tuerxun, Jesur Batur, Jian Huang, Jianqiu Kong, Tianxin Lin, Yuanyuan Ji
Publikováno v:
Chinese Medical Journal, Vol 137, Iss 9, Pp 1095-1104 (2024)
Abstract. Background:. Dual-energy computed tomography (DECT) is purported to accurately distinguish uric acid stones from non-uric acid stones. However, whether DECT can accurately discriminate ammonium urate stones from uric acid stones remains unk
Externí odkaz:
https://doaj.org/article/96b911d528564a3787d7b164ccf8e51c
Autor:
Jianqiu Kong, Yitong Zou, Hua Zhou, Yi Huang, Ying Lin, Shuogui Fang, Zhijian Chen, Junjiong Zheng, Yaqiang Huang, Zefeng Shen, Weibin Xie, Xinxiang Fan
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
BackgroundThe therapeutic effectiveness of immune checkpoint inhibitors (ICIs) in bladder cancer varies among individuals. Identifying reliable predictors of response to these therapies is crucial for optimizing patient outcomes.MethodsThis retrospec
Externí odkaz:
https://doaj.org/article/f025e47d0d24446e85fa16abb4c9b5ed
Autor:
Yi Huang, Ligang Chen, Yitong Zou, Hao Yu, Weibin Xie, Qinghua Gan, Yuhui Yao, Chengxiao Liao, Junjiong Zheng, jianqiu Kong, Tianxin Lin
Publikováno v:
Heliyon, Vol 10, Iss 11, Pp e31587- (2024)
Aims: To provide a comprehensive bibliometric overview of drug resistance in bladder cancer (BC) from 1999 to 2022, aiming to illuminate its historical progression and guide future investigative avenues. Methods: Literature on BC drug resistance betw
Externí odkaz:
https://doaj.org/article/eb00da550447474a8c6d982a8258456a
Publikováno v:
European Radiology Experimental, Vol 7, Iss 1, Pp 1-9 (2023)
Abstract Background Renal ischemia–reperfusion injury (IRI) frequently occurs clinically. We investigated the value of contrast-enhanced ultrasonography (CEUS) in the evaluation of renal IRI levels in mice. Methods Thirty-six healthy adult male C57
Externí odkaz:
https://doaj.org/article/dc270fe110de4d31918c1a9dbe304651
Autor:
Junjiong Zheng, Sihong Lu, Yi Huang, Xu Chen, Jie Zhang, Yuhui Yao, Jinhua Cai, Jieying Wu, Jianqiu Kong, Tianxin Lin
Publikováno v:
Journal of Translational Medicine, Vol 21, Iss 1, Pp 1-12 (2023)
Abstract Background Non-muscle invasive bladder cancer (NMIBC) is known for its elevated recurrence rate, necessitating an enhancement in the current risk stratification for recurrence. The urine-based fluorescence in situ hybridization (FISH) assay
Externí odkaz:
https://doaj.org/article/291946b8c3cb4d1991d0f325a24ecd09
Autor:
Yi Huang, Chengxiao Liao, Zefeng Shen, Yitong Zou, Weibin Xie, Qinghua Gan, Yuhui Yao, JunJiong Zheng, Jianqiu Kong
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
BackgroundNeoadjuvant chemotherapy (NAC) followed by radical cystectomy (RC) remains the cornerstone of treatment for muscle-invasive bladder cancer (MIBC). While platinum-based regimens have demonstrated benefits in tumor downstaging and improved lo
Externí odkaz:
https://doaj.org/article/27570f3cdb2e466eac395570aba1f880
Autor:
Jianqiu Kong, Junjiong Zheng, Jieying Wu, Shaoxu Wu, Jinhua Cai, Xiayao Diao, Weibin Xie, Xiong Chen, Hao Yu, Lifang Huang, Hongpeng Fang, Xinxiang Fan, Haide Qin, Yong Li, Zhuo Wu, Jian Huang, Tianxin Lin
Publikováno v:
Journal of Translational Medicine, Vol 20, Iss 1, Pp 1-12 (2022)
Abstract Background Preoperative diagnosis of pheochromocytoma (PHEO) accurately impacts preoperative preparation and surgical outcome in PHEO patients. Highly reliable model to diagnose PHEO is lacking. We aimed to develop a magnetic resonance imagi
Externí odkaz:
https://doaj.org/article/1ec7efa8f5c047379bb739ef8a1ddb65
Autor:
Jianqiu Kong, Sihong Lu, Long Zhang, Yuhui Yao, Jie Zhang, Zefeng Shen, Mingli Luo, Bin Liu, Junjiong Zheng, Tianxin Lin
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
PurposeImmune checkpoint blockade agents were shown to provide a survival advantage in urothelial carcinoma, while some patients got minimal benefit or side effects. Therefore, we aimed to investigate the prognostic value of m6A methylation regulator
Externí odkaz:
https://doaj.org/article/a1a28604eb1b4220ad3ec267275a0b9b
Autor:
Jintao Hu, Zhenming Zheng, Junjiong Zheng, Weibin Xie, Huabin Su, Jingtian Yang, Zixin Xu, Zefeng Shen, Hao Yu, Xinxiang Fan, Jianqiu Kong, Jinli Han
Publikováno v:
Frontiers in Oncology, Vol 11 (2022)
BackgroundA survival benefit was observed in metastatic bladder cancer patients who underwent primary tumor resection, but it was still confusing which patients are suitable for the surgery. For this purpose, we developed a model to screen stage M1 p
Externí odkaz:
https://doaj.org/article/49e8e57d04194b45885c1d8630d9076e